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Abstract: The aim of this study was to quantitate vascular endothelial growth factor (VEGF) and estradiol-17β in
follicular fluid (FF) and serum and to correlate the levels of these substances with oocyte maturation. Transvaginal
ultrasound-guided follicular aspirations were performed with the purpose of oocyte collection when the follicle was
>35 mm in diameter. The mares were divided into 2 groups according to age, and the changes in VEGF and estradiol17β in follicular fluid and serum were examined. Levels of estradiol-17β in the follicular fluid and serum of young
mares (4-10 years old) did not differ from those in old mares (20-24 years old) (P > 0.05). The follicular fluid and
serum concentrations of VEGF in old mares were lower (P < 0.001) than those in young mares. The VEGF levels in
young mares did not differ in cases when either mature or intermediate oocytes were collected, whereas its levels in old
mares were higher (P < 0.01) when mature oocytes were collected than when intermediate and immature oocytes were
collected. Our data suggest that VEGF may play an important role in follicular growth and development, that VEGF
levels appear to be age-dependent, and that VEGF levels might be valuable biochemical markers of oocyte maturation.
Key words: VEGF, oocyte maturation, follicular fluid, mare

Vasküler endotelyal büyüme faktörü (VEBF) ve total östradiol 17β kısrak oosit
maturasyonunda bir belirleyici olarak kullanılabilir mi?
Özet: Bu çalışmanın amacı folliküler sıvı (FS) ve serumda vasküler endotelyal büyüme faktörü (VEBF) ve total östradiol
17β’yı belirlemek ve bu maddelerin seviyelerini oosit maturasyonu ile ilişkilendirmektir. Follikül çapı 35 mm’den büyük
olduğunda; oosit toplama amacıyla transvajinal ultrason rehberliğinde follikül aspirasyonu gerçekleştirildi. Kısraklar
yaşa göre iki gruba ayrıldı ve VEBF ve östradiol 17β değişimleri folliküler sıvı ve serumda incelendi. Folliküler sıvı ve
serum östradiol 17β seviyeleri genç (4-10 yaş) ve yaşlı (20-24 yaş) kısrakların arasında farklı bulunmadı (P > 0,05).
Yaşlı kısrakların folliküler sıvı ve serum VEBF konsantrasyonları genç kısraklardakinden daha düşük bulundu (P <
0,001). Genç kısraklardan elde edilen VEFB seviyesi mature ve intermediate oositler arasında fark göstermezken; yaşlı
kısraklardan elde edilen VEFB seviyesi mature oositlerde intermediate ve immature oositlere göre daha yüksek bulundu
(P < 0,01). Yapılan çalışma sonucunda; VEBF’nün folliküler büyüme ve gelişimde önemli bir rol oynayabileceği,
VEBF seviyelerinin yaşa bağımlı gözüktüğü ve bu nedenle VEFB seviyeleri oosit maturasyonun değerli biyokimyasal
belirleyicisi olabileceği kanısına varıldı.
Anahtar sözcükler: VEBF, oosit maturasyonu, folliküler sıvı, kısrak
* E-mail: kasikci@istanbul.edu.tr
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Introduction

Materials and methods

Although the process of ovarian follicular
development and nuclear maturation of oocytes is
governed by conventional endocrine principles such
as pituitary gonadotropins and ovarian steroids,
recent observations suggest that gonadotropins
are only part of a complex system of autocrine and
paracrine agents, including growth factors (1).

The study was conducted during the breeding
season on younger (4-10 years old) and older (20-24
years old) non-lactating Arabian mares. Transvaginal
ultrasound-guided follicular aspirations were
performed with the purpose of oocyte collection
when the follicle was >35 mm in diameter.

Growth factors play a regulatory role in ovarian
function. Vascular endothelial growth factor
(VEGF), a protein thought to play a critical role in the
regulation of vascular permeability and angiogenesis
during embryogenesis and in pathological tissue
growth, is also expressed in the ovaries of numerous
species (2-4). VEGF production increases in
luteinizing granulosa cells of the ovulatory follicle as
well as in the developing corpus luteum in primates,
suggesting that this factor is important for vascular
changes associated with the transition of the follicle
to the corpus luteum (5).
In the ovary, VEGF is produced both by granulosa
and thecal cells (6,7). A recent study of macaque
granulosa cells suggested that VEGF expression
increases in response to gonadotrophins such as LH,
FSH, and human chorionic gonadotrophin (HCG)
(5).
In women with normal non-stimulated cycles and
those undergoing IVF, the local VEGF production in
follicular fluid is correlated with the degree of follicular
luteinization (8,9). Progesterone also appears to
play a role in determining VEGF concentration
in follicular fluid (10). A positive correlation has
been observed between follicular fluid VEGF
concentrations and patient age, especially in patients
≥38 years undergoing IVF (11,12). Recently, it has
been reported that elevated VEGF concentrations in
follicular fluid might predict poor conception rates
after IVF (13).
The aim of this study was to quantitate the VEGF
and total estradiol 17β in follicular fluid (FF) and
serum, and to correlate the levels of these substances
with oocyte maturation and mare age.
332

Oocytes were immediately identified, rinsed
twice in culture medium, and placed in a petri
dish containing 2.5 mL of culture medium (Tissue
Culture Medium 199 with additions of 10% fetal calf
serum, 0.2 mM pyruvate, and 50 μg/mL gentamicin).
Oocytes were incubated in air containing 6% CO2 at
38.5 °C for approximately 16 h.
Oocytes were graded based on morphology
(scores from 1, excellent, to 4, poor). Cumulus
expansion was graded as immature, intermediate,
or mature. Grades and maturity were assigned after
culture. Blood and follicular fluid were not used from
cycles in which oocytes were not recovered. Critical
evaluations of oocytes were difficult, as cumulus cells
frequently obstructed direct imaging of the oocyte
under a stereomicroscope.
Jugular blood (10 mL) was collected at the time
of follicular aspiration. Blood samples and follicular
fluid were centrifuged at 3500 × g for 15 min and
stored at –20 °C until being analyzed for VEGF
and estradiol-17β. Concentrations of estradiol
in follicular fluid and serum were estimated by
radioimmunoassay (RIA) using an active estradiol
RIA kit (active Estradiol RIA DSL-43100, Webster,
TX, USA). The amount of [125I]-labeled estradiol
bound to antibody is inversely proportional to the
concentration of unlabeled estradiol present. The
separation of free and bound antigen is achieved by
decanting or aspirating the antibody-coated tubes.
The sensitivity, defined as the lowest detectable
level of estradiol that can be distinguished from
the 0 pg/mL Estradiol Standard, is 11 pg/mL at the
95% confidence limit. The intra-assay precision was
determined from the mean of 12 replicates each
and the coefficient of variation was 2.01% when the
mean was 241.73 pg/mL. The inter-assay precision
was determined from the mean of average duplicates
for 24 separate runs and the coefficient of variation
was 7.37% when the mean was 247.48 pg/mL. The
assay has low cross-reactivity with equilenin (6.1%),

M. C. GÜNDÜZ, G. KAŞIKÇI, Ö. TURNA YILMAZ, S. Ö. ENGİNLER, M. UÇMAK, A. ATEŞ, F. ESEN GÜRSEL,
G. EVKURAN, M. D. TÖRE

estrone (3.4%), 17β-estradiol-3-glucuronide (1.8%),
estrone-β-d-glucuronide (0.3%), 16-ketoestradiol
(0.29%), 17α-estradiol (0.26%), estradiol-3-sulfate
(0.21%), estriol (0.75%), and equilin (0.84%). The
results were measured by gamma counter (MGM
Instruments, ISOCOMP I, USA).
Concentrations of VEGF in follicular fluid and
serum were assayed with the ELISA test kit for Equine
Vascular Endothelial Cell Growth Factor (USCN
Life Science Inc. Wuhan, China). The minimum
detectable dose of equine VEGF is typically less than
0.04 ng/mL. According to the manufacturer this
assay has high sensitivity and excellent specificity
for detection of equine VEGF. No significant crossreactivity or interference was observed.
The least squares procedures were used to analyze
for VEGF and total estradiol-17β. The model used
in the analysis included fixed effects of age (young
or old), sample (follicular fluid or serum) and
maturation (mature, intermediate, or immature) and
2-way interactions of these effects.

old mares (P > 0.05). Estradiol-17β level in follicular
fluid was higher (P < 0.001) than that in the serum
of the young and old mares. VEGF level in follicular
fluid was lower (P < 0.05) than that in the serum of
the young and old mares.
Oocyte grades varied (P < 0.05) with age, with
higher grades representing worse morphology scores
(young 4-10 years, 1.9 ± 0.1, n = 14 and old 20-24
years, 2.6 ± 0.2, n = 20).
VEGF level for young mares did not differ
between when mature and intermediate oocytes
were collected whereas its level for old mares when
mature oocytes were collected was higher (P < 0.01)
than when intermediate and immature oocytes were
collected (Figure).
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The mares were divided into 2 groups based on
age, and the changes in VEGF in follicular fluid and
serum were examined (Table). The follicular fluid
and serum concentrations of VEGF in old mares
were lower (P < 0.001) than those in young mares.
Levels of estradiol-17β in the follicular fluid and
serum of young mares did not differ from those in
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Figure.

intermediate
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The mean concentrations of VEGF for young and
old mares. Oocytes were classified as immature,
intermediate, or mature.

Table. The comparison of VEGF and estradiol-17β concentrations in follicular fluid (FF) and serum in
young and old mares.
VEGF (ng/mL)

Estradiol-17β

FF

Serum

FF (pg/mL)

Serum (ng/mL)

Young (n = 14)

3.46 ± 0.47

5.06 ± 0.47

250.7 ± 70.4

68.5 ± 7.2

Old (n = 20)

1.91 ± 0.5

2.9 ± 0.5

303.5 ± 67.3

53.3 ± 4.7

Significance
Age
Sample
Age & Sample

P < 0.001
P < 0.05
P > 0.05

P > 0.05
P < 0.001
P > 0.05
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Discussion
Estradiol-17 β and progesterone have been
suggested as markers for oocyte maturity and
fertilization in humans (14,15). On the other hand, it
has been reported that there is no correlation between
oocyte maturity and the concentrations of estradiol17β and progesterone in FF (16-19). Consequently,
no relationship between ovarian steroid hormones
and oocyte maturation was observed.
Therefore, we hypothesized that local factors, such
as growth factors produced in follicles, might act
upon follicular development and oocyte maturation
rather than ovarian steroid hormones in mares. In our
study the levels of estradiol-17β in the follicular fluid
and serum of young mares did not differ from those
in old mares. We previously (20) reported that IGF-I
and progesterone concentrations were significantly
reduced and correlated with oocyte maturation. IGF-I
levels in follicular fluid and serum were affected by
mare age, and the IGF-I concentrations in follicular
fluid from young mares were higher than those
from old mares. It was suggested that follicular fluid
levels of IGF-I and progesterone could be available
biochemical markers of oocyte maturation.
In the present study, we demonstrated that VEGF
is present in the follicular fluid. The follicular fluid
and serum concentrations of VEGF in old mares

were lower than those in young mares. Moreover,
VEGF levels in young mares were not different
between when mature and intermediate oocytes
were collected, whereas its levels in old mares when
mature oocytes were collected were higher than
when intermediate and immature oocytes were
collected. Kawano et al. (21) reported that VEGF
was increased in older women. Friedman et al.
(13) reported that VEGF in the FF of women of
advanced reproductive age was elevated compared
with that of younger women. They suggested that
the increasing VEGF level was caused by a hypoxic
environment within the follicles of older women.
It has been reported that VEGF did not reveal
significant differences in the mature group versus
immature oocytes, but VEGF with fertilized oocytes
was significantly higher than non-fertilized oocytes
in mature oocytes (22). Our data suggest that VEGF
may play an important role in follicular growth and
development, that VEGF levels appear to be agedependent, and that VEGF levels might be valuable
biochemical markers of oocyte maturation.
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